- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01477346
Arthritis Research UK Gout Treatment Trial - Phase 2
January 4, 2017 updated by: University of Nottingham
Arthritis Research UK Gout Treatment Trial. Phase 2: Two Year Randomised Controlled Trial of a Nurse Led Package of Care
The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
517
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nottingham, United Kingdom, NG5 1PB
- Academic Rheumatology, University of Nottingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of gout
- At least one acute attack of gout within previous 12 months
Exclusion Criteria:
- Inability to give informed consent and known terminal or mental illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Nurse intervention
Nurse led package of care based on current recommended best practice.
|
Complex package of care involving patient information and advice concerning lifestyle modification and recommended drug therapy.
|
Other: Standard care
Continuing standard general practitioner led care
|
Continuing standard General Practitioner led care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in serum uric acid levels
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in number of self reported acute attacks during year 2
Time Frame: 2 years
|
2 years
|
Improved Quality of Life scores at study end
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Doherty, MA MD FRCP, University of Nottingham
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
November 14, 2011
First Submitted That Met QC Criteria
November 18, 2011
First Posted (Estimate)
November 22, 2011
Study Record Updates
Last Update Posted (Estimate)
January 5, 2017
Last Update Submitted That Met QC Criteria
January 4, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11115 (DAIDS ES Registry Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gout
-
Ai PengRecruitingGout Flare | Intercritical Gout | Advanced Gout | Asymptomatic HyperuricemiaChina
-
AmgenCompletedUncontrolled Gout | Chronic GoutUnited States
-
Sheffield Hallam UniversityCherry Research CommitteeUnknown
-
Olatec Therapeutics LLCRecruitingArthritis | Joint Pain | Gout | Gout Flare | Gouty Arthritis | Acute Gout Flare | Gout AttackUnited States, Spain, France
-
GeneScience Pharmaceuticals Co., Ltd.Huashan HospitalNot yet recruitingAcute Gout | Gout Initiating Urico-lowering TherapyChina
-
GeneScience Pharmaceuticals Co., Ltd.Huashan HospitalRecruitingGout Flare | Acute GoutChina
-
AmgenCompletedGout | Chronic Uncontrolled Gout | Uncontrolled GoutUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout With Hyperuricemia in Adults
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout and Hyperuricemia
-
Guangdong Provincial Hospital of Traditional Chinese...RecruitingAcute Pain | Acupuncture | Acute Gout ArthritisChina
Clinical Trials on Nurse intervention
-
Institut de Recerca Biomèdica de LleidaCompleted
-
Duke UniversityAmerican Heart AssociationCompleted
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkRecruitingDiabete Type 2France
-
East Carolina UniversityVidant Medical CenterCompletedMedication AdherenceUnited States
-
London North West Healthcare NHS TrustKing's College London; Queen Mary University of LondonCompletedFecal Incontinence | Inflammatory Bowel Disease (IBD)United Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Unknown
-
Radboud University Medical CenterPICASSO: Partners in Care Solutions for COPDCompletedChronic Obstructive Pulmonary Disease | Health StatusNetherlands
-
US Department of Veterans AffairsCompleted
-
Milton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHypertension | Diabetes Mellitus | HyperlipidemiaUnited States
-
US Department of Veterans AffairsDialysis Clinic, Inc.; DaVita Dialysis; Liberty Dialysis, LLCCompletedDepression | Pain | End Stage Renal Disease | Sexual Dysfunction, PhysiologicalUnited States